TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive New Surgery Grant Applications To Be Reviews By Special Ad Hoc Study Section; 54 Submitted June 22, 1979
